Bret Jensen

AI infrastructure investments are driving U.S. economic growth, while other sectors lag. Here's what investors need to know about the U.S. economy.

Rigel Pharmaceuticals, Inc. posted a solid Q3 with robust sales growth. Discover insights on future profitability and market outlook. Click for this RIGL update.

NVIDIA's strong Q3 can't lift markets as the AI boom cools. Click to get insights on fading AI narratives, future stock market trends, and NVDA stock prospects.

Omeros stock rises after a $340 million deal with Novo Nordisk. Learn about its improved risk profile and covered call trade potential.

Explore why 2026 may bring falling home prices, with analysis on housing affordability, jobs, and market impacts.

The biotech sector, tracked by iShares Biotechnology ETF, rallied 40% in six months on rising M&A activity, still below four-year levels. Read why IBB ETF is a hold.

Discover five key warning signs for the U.S. economy and stocks. Click for a full review of the current market dynamic and why shares may be in for a tumble.

Read about the three major concerns prudent investors should have around the markets as we get into the New Year.

Collegium Pharmaceutical stock surged 15% after Q3 results beat forecasts. Click here to learn about COLL’s growth outlook and analyst upgrades.

Rising U.S. consumer debt threatens economic growth and retail earnings.